CVnCoV Withdrawn Phase 3 Trials for Coronavirus Disease 2019 (COVID‑19) Prevention

WithdrawnPrevention3 IdentifierTitleDrugs
NCT04848467COVID-19: A Trial Studying the SARS-CoV-2 mRNA Vaccine CVnCoV to Learn About the Immune Response, the Safety, and the Degree of Typical Vaccination Reactions When CVnCoV is Given at the Same Time as a Flu Vaccine Compared to When the Vaccines Are Separately Given in Adults 60 Years of Age and Older